← back to search

Tiantian Tang

Hebei Medical University · CN
Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research interests include Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Hepatocellular Carcinoma Treatment and Prognosis, and COVID-19 Clinical Research Studies.
h-index
13
citations
492
works
39
NIH funding
primary concept
email

Recent publications

A Novel Banana‐Based Gel System <scp>3D</scp> Printing: Effect of Oxygen Content in Printing Environment on Browning Development
Journal of Food Process Engineering 2025cited by 7position: middledoi
CircATP5C1 promotes triple-negative breast cancer progression by binding IGF2BP2 to modulate CSF-1 secretion
Cancer Biology & Therapy 2025cited by 2position: middledoi
Neoadjuvant chemotherapy is not necessarily applicable to patients with LN1-3 positive Luminal-B type operable breast cancer
Scientific Reports 2025cited by 0position: firstdoi
Identification of molecular subtypes based on chromatin regulator-related genes and experimental verification of the role of ASCL1 in conferring chemotherapy resistance to breast cancer
Frontiers in Immunology 2024cited by 3position: middledoi
Clinical practice guidelines for the diagnosis and treatment of inflammatory breast cancer: Chinese Society of Breast Surgery (CSBrS) Practice Guidelines 2022
Chinese Medical Journal 2023cited by 5position: middledoi
Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis
World Journal of Surgical Oncology 2023cited by 2position: middledoi
Effect of tumor-infiltrating lymphocytes depending on the presence of postmastectomy radiotherapy on the prognosis in pT1-2N1M0 breast cancer
Frontiers in Oncology 2023cited by 1position: middledoi
Prognosis and clinicopathological characteristics of metaplastic breast cancer: A meta-analysis
Medicine 2022cited by 11position: middledoi
Highly expressed SLCO1B3 inhibits the occurrence and development of breast cancer and can be used as a clinical indicator of prognosis
Scientific Reports 2021cited by 16position: firstdoi
Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021
Chinese Medical Journal 2021cited by 6position: middledoi
Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19
National Science Review 2020cited by 111position: middledoi
Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
Quality of Life Research 2020cited by 43position: middledoi
Gastric and adrenal metastasis from breast cancer
Medicine 2020cited by 18position: firstdoi
Diagnosis and treatment of advanced HER2-positive breast cancer in young pregnant female
Medicine 2020cited by 3position: firstdoi
Which is Better for Patients with Breast Cancer: Totally Implanted Vascular Access Devices (TIVAD) or Peripherally Inserted Central Catheter (PICC)?
World Journal of Surgery 2019cited by 20position: firstdoi
Repeated resection-associated breast angiosarcoma
Medicine 2018cited by 1position: firstdoi
Impact of next-generation sequencing (NGS) for primary endocrine resistance in breast cancer patients.
PubMed 2018cited by 1position: middle
Evaluation of ultrasound-diffuse optical tomography on the early efficacy of neoadjuvant chemotherapy for breast cancer
Zhonghua chaosheng yingxiangxue zazhi 2018cited by 0position: middledoi
Annexin A3 as a Prognostic Biomarker for Breast Cancer: A Retrospective Study
BioMed Research International 2017cited by 17position: middledoi
Analysis of the reason and handling measures of catheter fracture of the implantable vascular access device
˜The œJournal of practical nursing 2016cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Lina Zhang · Hebei Medical University5 papers (2017–2024)Cuizhi Geng · Hebei Medical University4 papers (2020–2025)Tao Zhou · Peking University Shenzhen Hospital3 papers (2017–2023)Yanshou Zhang · Hebei Medical University3 papers (2020–2023)Yuntao Li · Universidad del Noreste3 papers (2019–2025)Zhenchuan Song · Hebei Medical University2 papers (2018–2018)Meixiang Sang · Shanghai University of Electric Power2 papers (2021–2025)Yunjiang Liu · Hebei Medical University2 papers (2021–2024)Jianxin Wang · Zhejiang Ocean University2 papers (2019–2020)Chunxiao Li · Qingdao University2 papers (2021–2023)Haiping Li · Anhui Jianzhu University2 papers (2016–2019)Li Ma · Hebei Medical University1 papers (2024–2024)Xuan Guo · Central South University1 papers (2018–2018)Ling Xin · Cardiff University1 papers (2021–2021)Xuan Zhao · Nantong University1 papers (2021–2021)Yanli Xie · Florida State University1 papers (2020–2020)Yilun Li · Hebei Medical University1 papers (2024–2024)Tao Zhou · Shanxi Medical University1 papers (2019–2019)Yunjiang Liu · Hebei Medical University1 papers (2023–2023)Xiaolu Yang · Northwest Minzu University1 papers (2022–2022)